Alliance Pharma PLC Annual Report and AGM Notice (5754W)
April 28 2016 - 2:00AM
UK Regulatory
TIDMAPH
RNS Number : 5754W
Alliance Pharma PLC
28 April 2016
For immediate release 28 April 2016
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Annual Report and AGM Notice
Alliance Pharma plc (AIM: APH), the specialty pharmaceutical
company, announces that its 2015 Annual Report and Accounts and
Notice of Annual General Meeting, which will be held on 25 May
2016, are now available on the Company's website at
www.alliancepharma.co.uk.
Printed copies of both documents will be posted to shareholders
shortly and may also be requested by email at
ir@alliancepharma.co.uk.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Andrew Franklin, Chief Financial
Officer
Sarah Robinson, Company Secretary
www.alliancepharma.co.uk
+ 44 (0) 20 7466
Buchanan 5000
Mark Court / Sophie Cowles
/ Jane Glover
+ 44 (0) 20 7260
Numis Securities Limited 1000
Nominated Adviser: Michael
Meade / Freddie Barnfield
Corporate Broking: David
Poutney / James Black
Notes to Editors:
About Alliance Pharma
Alliance, founded in 1998, is an international speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has sales in more than 100 countries worldwide via direct
sales, joint ventures and a network of distributors. Alliance has a
strong track record of acquiring the rights to established niche
products and it currently owns or licenses the rights to
approximately 90 pharmaceutical and consumer healthcare products.
The Company continues to explore opportunities to expand its
product portfolio.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFMGZDVNVGVZM
(END) Dow Jones Newswires
April 28, 2016 02:00 ET (06:00 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024